Bibliographic record and links to related information available from the Library of Congress catalog. Note: Contents data are machine generated based on pre-publication information provided by the publisher. Contents may have variations from the printed book or be incomplete or contain other coding.
Cannabis: From Pariah to Prescription Introduction: Cannabis: From Pariah to Prescription Ethan Russo GW Pharmaceuticals List of Abbreviations and Definitions of Terms A Placebo-Controlled, Four Period, Crossover, Tolerability Study Assessing Pharmacodynamic Effects, Pharmacokinetic Characteristics and Cognitive Profiles of a Single Dose of Three Formulations of Cannabis Based Medicines Extracts (CBMEs) (GWPD9901), Plus Two Period Tolerability Study Comparing Pharmacodynamic Effects and Pharmacokinetic Characteristics of a Single Dose of a CBME Given via Two Administration Routes (GWPD9901 EXT) Amanda Martin S. Warrington M. Boyce K. Owen A Phase I, Open Label, Four-Way Crossover Study to Compare the Pharmacokinetic Profiles of a Single Dose of 20 mg of a Cannabis Based Medicine Extract (CBME) Administered on 3 Different Areas of the Buccal Mucosa and to Investigate the Pharmacokinetics of CBME Per Oral in Healthy Male and Female Volunteers (GWPK0112) Amanda Martin George Pohl Nicos Sarantis A Phase I, Double Blind, Three-Way Cross-Over Study to Assess the Pharmacokinetic Profile of Cannabis Based Medicine Extract (CBME) Administered Sublingually in Variant Cannabinoid Ratios in Normal Healthy Male Volunteers [STUDY CODE: GWPK0215] Amanda Martin G. Pohl Justin Richards CONTENTS 1 31 35 79 121 Cannabis and Cannabis-Based Medicine Extracts: Additional Results Ethan Russo Future of Cannabis and Cannabinoids in Therapeutics Ethan Russo Index 155 165 177
Library of Congress Subject Headings for this publication: Cannabinoids Therapeutic use, Cannabis Social aspects, Cannabinoids pharmacology, Cannabinoids therapeutic use, Phytotherapy, Placebos administration & dosage, Plant Extracts therapeutic use